Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Oral Naloxone to Prevent Post Spinal Fusion Ileus

NCT03176316 is registered in ClinicalTrials.gov with Loyola University as lead sponsor.

NCT NCT03176316
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03176316 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Oral Naloxone to Prevent Post Spinal Fusion Ileus
Lead sponsor
Loyola University
Phase
Phase 4
Overall status
Terminated
Start date
September 20, 2017
Completion date
February 20, 2020
Enrollment
53 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fusion of spine, ileus